Wave Life Sciences details Q3 2026 progress on WVE-006, WVE-007, WVE-008 pipelineOct 28Quarterly updateBristol Myers SquibbEli LillyUpdated
Lilly advances obesity and inflammation pipeline with new Phase 1 trials, Phase 2 updatesOct 9Weekly roundup, 10 itemsEli Lillyeloralintide
Lilly registers four new trials: Alzheimer's, cardiovascular, obesity, Crohn's programsAug 27Weekly roundup, 5 itemsclazakizumabEli Lilly
Lilly posts SURPASS-CVOT results; tirzepatide compared to dulaglutide on cardiovascular eventsJul 10Weekly roundup, 8 itemsAstraZenecabaricitinib